Zamansky LLC Investigates Unilife Corporation (UNIS) For Potential Securities Fraud
May 7, 2014
New York, NY (Law Firm Newswire) May 7, 2014 – Zamansky LLC announces that it is investigating Unilife Corporation (UNIS), the medical device manufacturer, for potential securities fraud or breach of fiduciary duties owed to shareholders. The investigation concerns whether Unilife made materially false or misleading statements to its investors, as alleged in a whistleblower lawsuit.
The federal court lawsuit was filed on August 30, 2013 (E. D. Pa. Case No. 13-CV-5101) by former employee Talbot Smith, and alleges not only false statements made to investors but a scheme whereby UNIS engaged in false purchases to boost the appearance of revenues.
According to stock fraud attorney Jake Zamansky, investors had the right to receive the truth. No company is permitted to deceive its investors, he states, and if a company does deceive its investors, it should be held accountable.
What UNIS Investors Can Do
If you are purchaser of UNIS stock from July 13, 2011 through September 9, 2013, or a are current long-term holder of UNIS stock, you may be eligible to file a legal proceeding. If wish to have your circumstances or investment reviewed or discuss your legal rights, you may, without obligation or cost to you, email jake(at)zamansky(dot)com or call the law firm at (212) 742-1414.
About Zamansky LLC
Zamansky LLC is a leading stock law firm specializing in securities and shareholder fraud and class actions. We are stock fraud attorneys who represent both individual and institutional investors. Our practice is nationally recognized for our ability to aggressively prosecute cases and recover investment losses.
To learn more about Zamansky LLC, please visit our website, http://www.zamansky.com.
50 Broadway – 32nd Floor
New York, NY 10004